RS52638B - Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors - Google Patents
Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitorsInfo
- Publication number
- RS52638B RS52638B RS20130038A RSP20130038A RS52638B RS 52638 B RS52638 B RS 52638B RS 20130038 A RS20130038 A RS 20130038A RS P20130038 A RSP20130038 A RS P20130038A RS 52638 B RS52638 B RS 52638B
- Authority
- RS
- Serbia
- Prior art keywords
- class
- inhibitors
- combination
- histone
- histone deacetylase
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Kombinacija, naznačena time, da obuhvata inhibitor proteasoma, pri čemu je pomenuti inhibitor proteasoma bortezomib, i inhibitor histonske deacetilaze, pri čemu je pomenuti inhibitor histonske deacetilaze jedinjenje Br. 1a (JNJ26481585)njegove farmaceutski prihvatljive kisele i bazne adicione soli i stereohemijski izomerne forme.Prijava sadrži još 7 patentnih zahteva.The combination comprising a proteasome inhibitor, said proteasome inhibitor being bortezomib, and a histone deacetylase inhibitor, said histone deacetylase inhibitor being compound Br. 1a (JNJ26481585) its pharmaceutically acceptable acid and base addition salts and stereochemically isomeric forms. The application contains 7 more claims.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06120726 | 2006-09-15 | ||
| US91589507P | 2007-05-03 | 2007-05-03 | |
| PCT/EP2007/059518 WO2008031817A2 (en) | 2006-09-15 | 2007-09-11 | Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS52638B true RS52638B (en) | 2013-06-28 |
Family
ID=41040414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20130038A RS52638B (en) | 2006-09-15 | 2007-09-11 | Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
Country Status (12)
| Country | Link |
|---|---|
| CN (1) | CN101516374B (en) |
| BR (1) | BRPI0716992A2 (en) |
| DK (1) | DK2066327T3 (en) |
| ES (1) | ES2399670T3 (en) |
| ME (1) | ME01514B (en) |
| NZ (1) | NZ575030A (en) |
| PT (1) | PT2066327E (en) |
| RS (1) | RS52638B (en) |
| SG (1) | SG177219A1 (en) |
| SI (1) | SI2066327T1 (en) |
| UA (1) | UA97249C2 (en) |
| ZA (1) | ZA200901818B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8957066B2 (en) * | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| CN115487191B (en) * | 2016-02-22 | 2024-05-14 | 中国科学院上海巴斯德研究所 | Quisinostat, a novel high-efficiency antimalarial drug |
| AU2017298473A1 (en) * | 2016-07-20 | 2019-01-24 | The Trustees Of Columbia University In The City Of New York | Histone acetyltransferase activators and compositions and uses thereof |
| CN114409638B (en) * | 2022-02-09 | 2023-02-14 | 深圳大学 | Histone deacetylase 8 selective degradation agent, preparation method and application thereof in antitumor activity |
| CN115028678A (en) * | 2022-07-08 | 2022-09-09 | 杭州医学院 | Bifunctional molecule based on BCR-ABL protein degradation induced by VHL ligand and preparation method and application thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG156687A1 (en) * | 2004-07-28 | 2009-11-26 | Janssen Pharmaceutica Nv | Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
-
2007
- 2007-09-11 PT PT78033974T patent/PT2066327E/en unknown
- 2007-09-11 DK DK07803397.4T patent/DK2066327T3/en active
- 2007-09-11 SI SI200731143T patent/SI2066327T1/en unknown
- 2007-09-11 NZ NZ575030A patent/NZ575030A/en unknown
- 2007-09-11 ME MEP-2013-15A patent/ME01514B/en unknown
- 2007-09-11 CN CN200780034143.2A patent/CN101516374B/en active Active
- 2007-09-11 BR BRPI0716992-2A2A patent/BRPI0716992A2/en not_active Application Discontinuation
- 2007-09-11 SG SG2011092863A patent/SG177219A1/en unknown
- 2007-09-11 RS RS20130038A patent/RS52638B/en unknown
- 2007-09-11 UA UAA200900388A patent/UA97249C2/en unknown
- 2007-09-11 ES ES07803397T patent/ES2399670T3/en active Active
-
2009
- 2009-03-13 ZA ZA200901818A patent/ZA200901818B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2066327E (en) | 2013-02-06 |
| ME01514B (en) | 2014-04-20 |
| ZA200901818B (en) | 2010-05-26 |
| ES2399670T3 (en) | 2013-04-02 |
| UA97249C2 (en) | 2012-01-25 |
| NZ575030A (en) | 2012-07-27 |
| BRPI0716992A2 (en) | 2013-09-17 |
| CN101516374A (en) | 2009-08-26 |
| CN101516374B (en) | 2013-04-24 |
| SG177219A1 (en) | 2012-01-30 |
| DK2066327T3 (en) | 2013-02-11 |
| SI2066327T1 (en) | 2013-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2019000185A (en) | A SOLID PHARMACEUTICAL DOSAGE FORMULATION | |
| NO20044444L (en) | Benzamide derivatives useful as histone deacetylase inhibitors | |
| AU2003219595A8 (en) | Alpha,beta-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors | |
| ATE425152T1 (en) | AMINOCARBONYL DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS | |
| ATE354366T1 (en) | HISTONE DEACETYLASE INHIBITORS | |
| WO2006066133A3 (en) | Histone deacetylase inhibitors | |
| WO2007139856A3 (en) | Heterobicyclic metalloprotease inhibitors | |
| EA200500239A1 (en) | A NEW METHOD OF SYNTHESIS (1S) -4-, 5-DIMETOXI-1- (METHYLAMINOMETHYL) -BENZO-CYCLOBUTANE AND ITS SALTS CONNECTION AND APPLICATION IN IVABRADIN SYNTHESIS AND ITS ITS SALTS CONNECTION WITH PHARMACETRECTRECTRECTRECTRATE SYSTEMS, which will be used in the synthesis of Ivabradine. | |
| RS52169B (en) | Stable laquinimod preparations | |
| NO20075051L (en) | Novel sulfonyl pyrrols and their use as histone deacetylase inhibitors | |
| RS52638B (en) | Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors | |
| RS52881B (en) | Benzamide compunds useful as histone deacetylase inhibitors | |
| UY28330A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING A HISTONE DEACETILASE INHIBITOR | |
| DK1542970T3 (en) | Pyrrolidine derivatives as MAOB inhibitors | |
| RS53063B (en) | Mglu2 agonists | |
| IL197426A0 (en) | Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors | |
| RS52108B (en) | 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses | |
| TW200724529A (en) | Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them | |
| EA200801875A1 (en) | ANTAGONIST CD 80 | |
| NO20052125L (en) | External preparation for inhibition of keloid formation | |
| RS50631B (en) | New association of agomelatine and a noradrenalin reuptake inhibitor, and pharmaceutical compositions containing them | |
| EE200800014A (en) | A pharmaceutical composition based on a p '' transcriptase inhibitor and meldonium | |
| HN2002000069A (en) | PCP INHIBITORS BASED ON ACIDS 3 - HYDROXAMIC HETEROCICLYLPROPANE. | |
| RU2005123928A (en) | NON-STEROID ANTI-INFLAMMATORY, ANALGETIC AGENT | |
| CL2008001363A1 (en) | Use of a histone deacetylase inhibitor for the treatment of melanoma. |